Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years
Clinical trial NCT01511250 · COMPLETED
Trial details
- NCT number
- NCT01511250
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-16
- Primary completion
- 2016-04-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.